Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VeradigmSTU:AL21 17 Net Margin % is -14.70% as of Dec. 2022. GuruFocus rates STU:AL21 with a GF Score™ of 17/100. Among 666 Healthcare Providers & Services companies, Veradigm ranks worse than 150150% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Veradigm's Net Income for the
six
months ended in Dec. 2022 was €-81.6 Mil. Veradigm's Revenue for the
six
months ended in Dec. 2022 was €555.1 Mil. Therefore, Veradigm's net margin for the quarter that ended in Dec. 2022 was -14.70%.
The historical rank and industry rank for Veradigm's Net Margin % or its related term are showing as below:
STU:AL21's Net Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.895 * Ranked among companies with meaningful Net Margin % only.
Veradigm (STU:AL21) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Veradigm Net Margin % Related Terms
Veradigm Net Margin % Historical Data
* Premium members only.
The historical data trend for Veradigm's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AL21 vs CTEV, EVH, PHR: Net Margin % Comparison
For the Health Information Services subindustry, Veradigm's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veradigm Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's Net Margin % distribution charts can be found below:
* The bar in red indicates where Veradigm's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veradigm (STU:AL21) has a Net Margin % of -14.70% as of Dec. 2022. Net margin is the ratio of total net income to net sales. View historical data on Veradigm and its competitors. According to the industry distribution chart, Veradigm ranks #999999 out of 666 companies in the Healthcare Providers & Services industry.
Is Veradigm's Net Margin % too high?
Veradigm's current Net Margin % is -14.70%. Based on the distribution chart, Veradigm ranks #999999 out of 666 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Veradigm has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Veradigm's Net Margin % compare to CTEV and EVH?
According to the Healthcare Providers & Services industry distribution chart, Veradigm ranks #999999 out of 666 companies for Net Margin %. This places Veradigm in the lower half of its industry. The industry median Net Margin % is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.90, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Veradigm and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veradigm's current Net Margin % is -14.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradigm stock overvalued right now?
Veradigm (STU:AL21) has a current Net Margin % of -14.70%. The current Net Margin % is -14.70%. Veradigm's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Veradigm (STU:AL21), the current Net Margin % is -14.70% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.
17GF Score
Get the complete analysis for STU:AL21
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AL21 has been successfully added to your 
